Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant
Clinical trial NCT01019577 · COMPLETED
Trial details
- NCT number
- NCT01019577
- Sponsor
- R-Pharm
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.